Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024
-
Ryan White and World AIDS Day 2022
Learn about World AIDS Day and activities of HRSA's Ryan White HIV/AIDS Program.
Blog updated 11/09/2023
-
PrEP Policies and Programs Help End the HIV Epidemic
Summary of pre-exposure prophylaxis (PrEP) provisions under HRSA and the Ryan White HIV/AIDS Program and PrEP resources on coverage and costs and providers with PrEP expertise.
Blog updated 11/14/2023
-
Recap: 17th Ryan White HIV/AIDS Program Clinical Care Conference
Highlights from the 2017 Ryan White Clinical Conference by Dr. Laura Cheever.
Blog updated 01/13/2023
-
Toolkit Features State Strategies to Improve the Health of People with HIV
HHS has supported development of a toolkit on state Medicaid and health department coordination to improve HIV care delivery.
Blog updated 12/28/2022
-
Is Medicare About to Cover PrEP Under Part B?
Is Medicare going to adopt the practice of private health insurance and start covering PrEP without cost-sharing under Part B?News Article updated on 05/14/2024 -
More from CROI: DoxyPEP, Long-Acting ART
The latest and perhaps final summary of HIV.gov insights from CROI 2024 focuses on Doxy-PEP (prevention of STIs) and long-acting antiretroviral therapies.News Article updated on 03/14/2024 -
Mpox Emergency is Over
The mpox emergency declaration ended at the end of January 2023.News Article updated on 02/02/2023 -
Ryan White and HIV Testing
RWHAP activities to enhance HIV testing in order to bring more infected persons into care.
Blog updated 05/28/2024